{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-023580","form_type":"8-K","ticker":"PPCB","cik":"0001517681","company_name":"Propanc Biopharma, Inc.","filed_at":"2025-08-13T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.195372+00:00","generated_at":"2026-05-17T13:55:11.855333+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Propanc Biopharma appoints Jeannine Zimmerman as CFO effective Aug 13, 2025","bullets":["Jeannine Zimmerman, age 48, appointed CFO effective August 13, 2025.","She holds a B.S. in accounting from St. Joseph's College; experience includes SEC filings, audit, and SOX 404 testing.","Prior to appointment, CEO James Nathanielsz had served as both CEO and CFO."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-023580","json":"https://secwatch.observer/filing/0001641172-25-023580.json","markdown":"https://secwatch.observer/filing/0001641172-25-023580.md","text":"https://secwatch.observer/filing/0001641172-25-023580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/0001641172-25-023580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517681/000164117225023580/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:55:11.855333+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}